Financhill
Buy
72

CHR.TO Quote, Financials, Valuation and Earnings

Last price:
$21.11
Seasonality move :
8.43%
Day range:
$21.11 - $21.44
52-week range:
$17.62 - $24.31
Dividend yield:
0.76%
P/E ratio:
8.77x
P/S ratio:
0.42x
P/B ratio:
0.89x
Volume:
54.3K
Avg. volume:
49.9K
1-year change:
2.93%
Market cap:
$494.3M
Revenue:
$1.4B
EPS (TTM):
-$1.63

Analysts' Opinion

  • Consensus Rating
    Chorus Aviation, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $29.67, Chorus Aviation, Inc. has an estimated upside of 40.53% from its current price of $21.11.
  • Price Target Downside
    According to analysts, the lowest downside price target is $27.00 representing 100% downside risk from its current price of $21.11.

Fair Value

  • According to the consensus of 4 analysts, Chorus Aviation, Inc. has 40.53% upside to fair value with a price target of $29.67 per share.

CHR.TO vs. S&P 500

  • Over the past 5 trading days, Chorus Aviation, Inc. has underperformed the S&P 500 by -2.46% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Chorus Aviation, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Chorus Aviation, Inc. revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Chorus Aviation, Inc. reported revenues of $323.6M.

Earnings Growth

  • Chorus Aviation, Inc. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Chorus Aviation, Inc. reported earnings per share of $0.41.
Enterprise value:
813.2M
EV / Invested capital:
--
Price / LTM sales:
0.42x
EV / EBIT:
8.85x
EV / Revenue:
0.60x
PEG ratio (5yr expected):
0.10x
EV / Free cash flow:
25.03x
Price / Operating cash flow:
17.28x
Enterprise value / EBITDA:
3.86x
Gross Profit (TTM):
$91.9M
Return On Assets:
0.69%
Net Income Margin (TTM):
0.94%
Return On Equity:
2.28%
Return On Invested Capital:
1.13%
Operating Margin:
7.68%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $1.6B $1.4B $1.3B $342M $323.6M
Gross Profit $228.5M $110.1M $91.9M $26.9M $24.8M
Operating Income $228.5M $110.1M $91.9M $26.9M $24.8M
EBITDA $375.6M $212.1M $210.7M $53.6M $51.6M
Diluted EPS $0.92 $0.03 -$1.63 $0.10 $0.41
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $425.5M $487.1M $528.6M $2.4B $328M
Total Assets $3.3B $4.2B $3.9B $3.5B $1.3B
Current Liabilities $449.6M $709.1M $697.9M $2.1B $268.1M
Total Liabilities $2.6B $3B $2.6B $2.8B $779M
Total Equity $685.8M $1.3B $1.3B $645.5M $554.4M
Total Debt $2.1B $2.3B $1.8B $661.2M $345.4M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $359.1M $254.5M $71.2M $52.6M $39.2M
Cash From Investing $140.8M $122.1M $673.2M $32M -$14.3M
Cash From Financing -$543.1M -$373.6M -$927.9M -$76.7M -$55.1M
Free Cash Flow $305.2M $200.6M $32.5M $43M $26.8M
CHR.TO
Sector
Market Cap
$494.3M
$486.6M
Price % of 52-Week High
86.84%
79.89%
Dividend Yield
0.76%
0%
Shareholder Yield
18.56%
1.54%
1-Year Price Total Return
2.93%
--
Beta (5-Year)
1.598
0.550
Dividend yield:
0.76%
Annualized payout:
$0.00
Payout ratio:
19.24%
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $21.52
200-day SMA
Sell
Level $21.11
Bollinger Bands (100)
Sell
Level 20.55 - 22.89
Chaikin Money Flow
Sell
Level -2.3M
20-day SMA
Sell
Level $21.73
Relative Strength Index (RSI14)
Sell
Level 36.95
ADX Line
Sell
Level 20.4
Williams %R
Buy
Level -100
50-day SMA
Sell
Level $22.42
MACD (12, 26)
Sell
Level -0.26
25-day Aroon Oscillator
Buy
Level 4
On Balance Volume
Sell
Level -8.3M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.6365)
Sell
CA Score (Annual)
Level (-0.971)
Buy
Beneish M-Score (Annual)
Level (-3.6928)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-2.3855)
Buy
Piotroski F Score (Annual)
Level (6)
Sell
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Chorus Aviation, Inc. is a holding company, which engages in the provision of aviation services. It operates through the Regional Aircraft Leasing and Regional Aviation Services segments. The Regional Aircraft Leasing segment provides aircraft leasing to third-party air operators through its subsidiary Chorus Aviation Capital. The Regional Aviation Services segment includes contract flying; aircraft leasing; maintenance, repair and overhaul, and part sales and technical services; and pilot training. The company was founded on November 25, 2005 and is headquartered in Dartmouth, Canada.

Stock Forecast FAQ

In the current month, CHR.TO has received 3 Buy ratings 1 Hold ratings, and 0 Sell ratings. The CHR.TO average analyst price target in the past 3 months is $29.67.

  • Where Will Chorus Aviation, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Chorus Aviation, Inc. share price will rise to $29.67 per share over the next 12 months.

  • What Do Analysts Say About Chorus Aviation, Inc.?

    Analysts are divided on their view about Chorus Aviation, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Chorus Aviation, Inc. is a Sell and believe this share price will drop from its current level to $27.00.

  • What Is Chorus Aviation, Inc.'s Price Target?

    The price target for Chorus Aviation, Inc. over the next 1-year time period is forecast to be $29.67 according to 4 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is CHR.TO A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Chorus Aviation, Inc. is a Buy. 3 of 4 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of CHR.TO?

    You can purchase shares of Chorus Aviation, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Chorus Aviation, Inc. shares.

  • What Is The Chorus Aviation, Inc. Share Price Today?

    Chorus Aviation, Inc. was last trading at $21.11 per share. This represents the most recent stock quote for Chorus Aviation, Inc.. Yesterday, Chorus Aviation, Inc. closed at $21.11 per share.

  • How To Buy Chorus Aviation, Inc. Stock Online?

    In order to purchase Chorus Aviation, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Is Berkshire Hathaway Stock Undervalued?
Is Berkshire Hathaway Stock Undervalued?

Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…

Is Oracle Stock Undervalued?
Is Oracle Stock Undervalued?

Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
57
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 38x

Alerts

Sell
1
LW alert for Dec 20

Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.

Buy
54
BMRN alert for Dec 20

BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.

Buy
82
RKLB alert for Dec 20

Rocket Lab Corp. [RKLB] is up 17.72% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock